MIRA MIRA PHARMACTLS

$0.78

MIRA PHARMACTLS (MIRA) is expected to report earnings on November 11, 2026, before the market open.

MIRA PHARMACTLS Reported Earnings
Wednesday, August 12, 2026 · 12:00 AM ET
Earnings Date
Nov 11
Wednesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About MIRA PHARMACTLS

MIRA Pharmaceuticals Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. MIRA Pharmaceuticals Inc. is based in Baltimore, Maryland.